Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients

Daniele Lilleri, Giuseppe Gerna, Francesca Bruno, Paola Draghi, Elisa Gabanti, Chiara Fornara, Federica Meloni

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

It is debated whether human cytomegalovirus (HCMV) infection/disease of the pulmonary compartment in lung transplant recipients (LTRs) may be controlled by the HCMV-specific systemic T-cell response or requires a local (lung) T-cell response. Systemic and local HCMV loads were investigated in parallel by real-time PCR in 20 LTRs. T-cell responses were measured by intracellular cytokine staining of HCMV-specific IFN-γ+ CD4+ and CD8+ T-cells in PBMC, and by enzyme-linked immunospot (ELISpot) assay in lung (BAL) mononuclear cells. Patients were grouped at time of peak of infection based on viral load in blood and BAL. Immunological testing results showed that five patients with no HCMV infection (either local or systemic) had both local and systemic T-cell responses; four patients with systemic infection had no systemic T-cell response; five patients with both systemic and lung infection had neither local nor systemic T-cell responses; and six patients with lung infection had no local and a partial (only CD8+ in the absence of CD4+) systemic T-cell response. These results indicate that local immunity is associated with resolution of lung infection. Systemic T-cell response alone is not sufficient to provide lung protection from HCMV infection.

Original languageEnglish
Pages (from-to)267-277
Number of pages11
JournalNew Microbiologica
Volume36
Issue number3
Publication statusPublished - Jul 2013

Fingerprint

Cytomegalovirus
T-Lymphocytes
Lung
Cytomegalovirus Infections
Dimercaprol
Infection
Transplant Recipients
Enzyme-Linked Immunospot Assay
Viral Load
Lung Diseases
Real-Time Polymerase Chain Reaction
Immunity
Staining and Labeling
Cytokines

Keywords

  • Enzyme-linked immunospot (ELISpot) assay
  • Intracellular cytoplasmic staining
  • Local (lung) HCMV immunity
  • Lung transplant recipients
  • Systemic HCMV T-cell immunity

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients. / Lilleri, Daniele; Gerna, Giuseppe; Bruno, Francesca; Draghi, Paola; Gabanti, Elisa; Fornara, Chiara; Meloni, Federica.

In: New Microbiologica, Vol. 36, No. 3, 07.2013, p. 267-277.

Research output: Contribution to journalArticle

Lilleri, Daniele ; Gerna, Giuseppe ; Bruno, Francesca ; Draghi, Paola ; Gabanti, Elisa ; Fornara, Chiara ; Meloni, Federica. / Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients. In: New Microbiologica. 2013 ; Vol. 36, No. 3. pp. 267-277.
@article{9b7a86c0d294446ebbdac64a5490b180,
title = "Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients",
abstract = "It is debated whether human cytomegalovirus (HCMV) infection/disease of the pulmonary compartment in lung transplant recipients (LTRs) may be controlled by the HCMV-specific systemic T-cell response or requires a local (lung) T-cell response. Systemic and local HCMV loads were investigated in parallel by real-time PCR in 20 LTRs. T-cell responses were measured by intracellular cytokine staining of HCMV-specific IFN-γ+ CD4+ and CD8+ T-cells in PBMC, and by enzyme-linked immunospot (ELISpot) assay in lung (BAL) mononuclear cells. Patients were grouped at time of peak of infection based on viral load in blood and BAL. Immunological testing results showed that five patients with no HCMV infection (either local or systemic) had both local and systemic T-cell responses; four patients with systemic infection had no systemic T-cell response; five patients with both systemic and lung infection had neither local nor systemic T-cell responses; and six patients with lung infection had no local and a partial (only CD8+ in the absence of CD4+) systemic T-cell response. These results indicate that local immunity is associated with resolution of lung infection. Systemic T-cell response alone is not sufficient to provide lung protection from HCMV infection.",
keywords = "Enzyme-linked immunospot (ELISpot) assay, Intracellular cytoplasmic staining, Local (lung) HCMV immunity, Lung transplant recipients, Systemic HCMV T-cell immunity",
author = "Daniele Lilleri and Giuseppe Gerna and Francesca Bruno and Paola Draghi and Elisa Gabanti and Chiara Fornara and Federica Meloni",
year = "2013",
month = "7",
language = "English",
volume = "36",
pages = "267--277",
journal = "New Microbiologica",
issn = "1121-7138",
publisher = "Luigi Ponzio e figlio Editori",
number = "3",

}

TY - JOUR

T1 - Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients

AU - Lilleri, Daniele

AU - Gerna, Giuseppe

AU - Bruno, Francesca

AU - Draghi, Paola

AU - Gabanti, Elisa

AU - Fornara, Chiara

AU - Meloni, Federica

PY - 2013/7

Y1 - 2013/7

N2 - It is debated whether human cytomegalovirus (HCMV) infection/disease of the pulmonary compartment in lung transplant recipients (LTRs) may be controlled by the HCMV-specific systemic T-cell response or requires a local (lung) T-cell response. Systemic and local HCMV loads were investigated in parallel by real-time PCR in 20 LTRs. T-cell responses were measured by intracellular cytokine staining of HCMV-specific IFN-γ+ CD4+ and CD8+ T-cells in PBMC, and by enzyme-linked immunospot (ELISpot) assay in lung (BAL) mononuclear cells. Patients were grouped at time of peak of infection based on viral load in blood and BAL. Immunological testing results showed that five patients with no HCMV infection (either local or systemic) had both local and systemic T-cell responses; four patients with systemic infection had no systemic T-cell response; five patients with both systemic and lung infection had neither local nor systemic T-cell responses; and six patients with lung infection had no local and a partial (only CD8+ in the absence of CD4+) systemic T-cell response. These results indicate that local immunity is associated with resolution of lung infection. Systemic T-cell response alone is not sufficient to provide lung protection from HCMV infection.

AB - It is debated whether human cytomegalovirus (HCMV) infection/disease of the pulmonary compartment in lung transplant recipients (LTRs) may be controlled by the HCMV-specific systemic T-cell response or requires a local (lung) T-cell response. Systemic and local HCMV loads were investigated in parallel by real-time PCR in 20 LTRs. T-cell responses were measured by intracellular cytokine staining of HCMV-specific IFN-γ+ CD4+ and CD8+ T-cells in PBMC, and by enzyme-linked immunospot (ELISpot) assay in lung (BAL) mononuclear cells. Patients were grouped at time of peak of infection based on viral load in blood and BAL. Immunological testing results showed that five patients with no HCMV infection (either local or systemic) had both local and systemic T-cell responses; four patients with systemic infection had no systemic T-cell response; five patients with both systemic and lung infection had neither local nor systemic T-cell responses; and six patients with lung infection had no local and a partial (only CD8+ in the absence of CD4+) systemic T-cell response. These results indicate that local immunity is associated with resolution of lung infection. Systemic T-cell response alone is not sufficient to provide lung protection from HCMV infection.

KW - Enzyme-linked immunospot (ELISpot) assay

KW - Intracellular cytoplasmic staining

KW - Local (lung) HCMV immunity

KW - Lung transplant recipients

KW - Systemic HCMV T-cell immunity

UR - http://www.scopus.com/inward/record.url?scp=84883162770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883162770&partnerID=8YFLogxK

M3 - Article

C2 - 23912868

AN - SCOPUS:84883162770

VL - 36

SP - 267

EP - 277

JO - New Microbiologica

JF - New Microbiologica

SN - 1121-7138

IS - 3

ER -